During the past decade, Sheba Medical Center conducted 686 clinical trials. In the 10-year time frame, 686 clinical trials started and 221 clinical trials were completed, i.e. on average, 32.2% percent of trials that started reached the finish line to date. In the past 5 years, 291 clinical trials started and 158 clinical trials were completed. i.e. 54.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sheba Medical Center" #1 sponsor was "Sheba Medical Center" with 369 trials, followed by "Janssen Research & Development, LLC" with 41 trials sponsored, "Eli Lilly and Company" with 36 trials sponsored, "Pfizer" with 26 trials sponsored and "Hoffmann-La Roche" with 26 trials sponsored. Other sponsors include 632 different institutions and companies that sponsored additional 377 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sheba Medical Center" #1 collaborator was "Sheba Medical Center" with 27 trials as a collaborator, "Eli Lilly and Company" with 11 trials as a collaborator, "Merck Sharp & Dohme LLC" with 11 trials as a collaborator, "AstraZeneca" with 9 trials as a collaborator and "Tel Aviv University" with 9 trials as a collaborator. Other collaborators include 375 different institutions and companies that were collaborators in the rest 263 trials.

According to Clinical.Site data, the most researched conditions in "Sheba Medical Center" are "Breast Cancer" (22 trials), "Multiple Myeloma" (22 trials), "Crohn's Disease" (21 trials), "Ulcerative Colitis" (14 trials) and "Carcinoma, Non-Small-Cell Lung" (12 trials). Many other conditions were trialed in "Sheba Medical Center" in a lesser frequency.

Most popular intervention types in "Sheba Medical Center" are "Drug" (631 trials), "Device" (161 trials), "Other" (141 trials), "Biological" (84 trials) and "Procedure" (58 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (183 trials), "Pembrolizumab" (18 trials), "placebo" (18 trials), "Dexamethasone" (17 trials) and "Cyclophosphamide" (14 trials). Other intervention names were less common.

The vast majority of trials in "Sheba Medical Center" are 978 trials for "All" genders, 96 trials for "Female" genders and 56 trials for "Male" genders.

Currently, there are 317 active trials in "Sheba Medical Center". 6 are not yet recruiting, 192 are recruiting, 115 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 445 completed trials in Sheba Medical Center, 7 suspended trials, and 89 terminated clinical trials to date.

Out of the total trials that were conducted in Sheba Medical Center, 97 "Phase 1" clinical trials were conducted, 244 "Phase 2" clinical trials and 364 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 50 trials, and there were also 230 trials that are defined as “Not Applicable".

Sheba Medical Center has several departments that took part in Clinical trials: "Chaim Sheba Medical Center; Oncology Dept" - 25 trials, "Leviev Heart Center, Chaim Sheba Medical Center" - 10 trials, "Chaim Sheba Medical Center; Hematology BMT & CBB" - 6 trials, "Sheba Medical Center, Cardiac Rehabilitation Institute" - 5 trials, "Sheba Medical Center rehabilitaion facility" - 4 trials, "Gastroenterology Institute" - 4 trials, "The Edmond and Lily Safra Children's Hospital - Sheba Medical Center" - 4 trials, "Center of Geographic Medicine" - 3 trials, "Chaim Sheba Medical Center; Pediatrics B North and Pediatric Endocrinology Unit" - 2 trials, "Department of Neurology & Sagol Neuroscience Center" - 2 trials, "Department of Orthopedic Rehabilitation, Sheba Medical Center" - 2 trials, "Sheba Medical Center, Pulmonology department" - 2 trials, "Chaim Sheba Medical Center; Allergy and Clinical Immunology Unit" - 2 trials, "Sheba Medical Center - Neonatal Department" - 2 trials, "ADHD Medical Clinic, Child and Adolescent Psychiatry Unit, Sheba Medical Center" - 2 trials, "Burn Unit, Sheba Medical Center" - 2 trials, "Psychiatry Clinic - Sheba Medical Center" - 2 trials